Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-FR Version v1-EN
Language French English
Date Updated 2022-08-03 2022-03-17
Drug Identification Number 02281074 02281074
Brand name ACZONE ACZONE
Common or Proper name ACZONE ACZONE
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients DAPSONE DAPSONE
Strength(s) 5% 5%
Dosage form(s) GEL GEL
Route of administration TOPICAL TOPICAL TOPICAL TOPICAL
Packaging size 60g 60g
ATC code D10AX D10AX
ATC description ANTI-ACNE PREPARATIONS FOR TOPICAL USE ANTI-ACNE PREPARATIONS FOR TOPICAL USE
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2022-05-17 2022-04-26
Actual start date 2022-05-18
Estimated end date 2022-07-29 2022-06-23
Actual end date 2022-08-01
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments production delay production delay
Health Canada comments